Aptose Biosciences (APS) News Today C$0.30 0.00 (0.00%) As of 01/20/2025 02:01 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Aptose Biosciences, Inc.: Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY TrialJanuary 10, 2025 | finanznachrichten.deAptose and NCI Collaborate on Cancer Drug TrialsDecember 3, 2024 | markets.businessinsider.comAptose Biosciences Boosts Capital with $8M OfferingNovember 27, 2024 | markets.businessinsider.comAptose Biosciences Announces $8 Million Public OfferingNovember 22, 2024 | markets.businessinsider.comAptose Biosciences Launches TUSCANY Study for AMLNovember 21, 2024 | markets.businessinsider.comAptose Biosciences Inc. (APS.TO)November 19, 2024 | ca.finance.yahoo.comAptose Biosciences, Inc.: Aptose Reports Results for the Second Quarter 2024August 9, 2024 | finanznachrichten.deClosing Bell: Aptose Biosciences Inc up on Wednesday (APS)August 8, 2024 | theglobeandmail.comAptose Biosciences: Top 10 Undervalued Healthcare Sector Stocks on TSX (APS)July 25, 2024 | theglobeandmail.comAptose Biosciences, Inc.: Aptose Announces Receipt of Deficiency Notice from NasdaqJuly 20, 2024 | finanznachrichten.deClosing Bell: Aptose Biosciences Inc flat on Thursday (APS)May 17, 2024 | theglobeandmail.comBuy Rating for Aptose Biosciences on Tuspetinib’s Promising AML Study and Synergistic PotentialMay 17, 2024 | markets.businessinsider.comAptose Biosciences, Inc.: Aptose Reports Results for the First Quarter 2024May 15, 2024 | finanznachrichten.deAPTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024May 14, 2024 | msn.comAptose Biosciences: Q1 Earnings SnapshotMay 14, 2024 | sfgate.comAptose Biosciences Q1 Net Loss Falls, on Lower ExpensesMay 14, 2024 | finance.yahoo.comAptose Biosciences Inc. (APTO) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | seekingalpha.comAptose Biosciences's Earnings: A PreviewMarch 25, 2024 | benzinga.comAptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment OptionJanuary 31, 2024 | finance.yahoo.comClosing Bell: Aptose Biosciences Inc flat on Wednesday (APS)December 20, 2023 | theglobeandmail.comAptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual MeetingDecember 9, 2023 | finance.yahoo.comAptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive RoleNovember 30, 2023 | finance.yahoo.comAptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finance.yahoo.comAptose Reports Results for the Third Quarter 2023November 9, 2023 | finance.yahoo.comAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual MeetingNovember 2, 2023 | theglobeandmail.comAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual MeetingNovember 2, 2023 | finance.yahoo.comAptose Biosciences, Inc.: Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug TuspetinibOctober 30, 2023 | finanznachrichten.deAptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023October 26, 2023 | finance.yahoo.comPromising Prospects of Tuspetinib Drive Buy Rating for Aptose Biosciences: An Analyst’s PerspectiveOctober 20, 2023 | markets.businessinsider.comClosing Bell: Aptose Biosciences Inc up on Friday (APS)October 7, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc up on Thursday (APS)August 25, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Monday (APS)August 22, 2023 | theglobeandmail.comAptose Biosciences, Inc.: Aptose Reports Results for the Second Quarter 2023August 11, 2023 | finanznachrichten.deAptose Reports Results for the Second Quarter 2023August 11, 2023 | finance.yahoo.comAptose Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (APS)August 7, 2023 | theglobeandmail.comAptose Biosciences: Stocks Undervalued by Analyst Consensus on TSX (APS)July 21, 2023 | theglobeandmail.comAptose Biosciences, Inc.: Aptose Biosciences Meets Nasdaq Minimum Bid Price ComplianceJune 27, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Biosciences Provides Update on Reverse Stock SplitJune 5, 2023 | finanznachrichten.deAptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023May 31, 2023 | finance.yahoo.comAptose to sell up to $25M stock in the U.S.May 26, 2023 | seekingalpha.comClosing Bell: Aptose Biosciences Inc flat on Tuesday (APS)May 17, 2023 | theglobeandmail.comAptose Biosciences Inc.'s (TSE:APS) Path To ProfitabilityMay 11, 2023 | finance.yahoo.comClosing Bell: Aptose Biosciences Inc down on Wednesday (APS)May 10, 2023 | theglobeandmail.comAptose Reports Results for the First Quarter 2023May 8, 2023 | finance.yahoo.comAptose to Participate in RBC Capital Markets 2023 Global Healthcare ConferenceMay 4, 2023 | finance.yahoo.comClosing Bell: Aptose Biosciences Inc up on Monday (APS)May 2, 2023 | theglobeandmail.comAptose Biosciences to Participate in Cantor’s The Future of Oncology Virtual SymposiumMarch 28, 2023 | finance.yahoo.comAptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Call TranscriptMarch 27, 2023 | finance.yahoo.comAptose Biosciences, Inc.: Aptose Reports Results for the Fourth Quarter and Full Year 2022March 25, 2023 | finanznachrichten.deAptose Reports Immaterial Financial Exposure to Silicon Valley BankMarch 10, 2023 | finance.yahoo.com Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Email Address APS Media Mentions By Week APS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APS News Sentiment▼0.000.49▲Average Medical News Sentiment APS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APS Articles This Week▼00▲APS Articles Average Week Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SBM News Today RVX News Today KNE News Today IOT News Today QPT News Today FRX News Today TH News Today MDNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:APS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptose Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APS Stock Alerts